Feedback / Questions
pegtarazimod (RLS-0071) - ReAlta
https://www.businesswire.com/news/home/20251204682621/en/ReAlta-Announces-Promising-Phase-2-Data-Demonstrating-Rapid-Clinical-Responses-and-Target-Engagement-in-Steroid-Refractory-Acute-GvHD-at-the-ASH-2025-Annual-Meeting
Dec 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next